- Home
- Dermatology
Evaluating Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa

20233 min read
Medical Article
Dystrophic epidermolysis bullosa is a rare genetic blistering disease due to mutations in COL7A1, the gene encoding type VII collagen (C7), causes absent or dysfunctional anchoring fibrils and which interrupts adhesion of the epidermis to the dermis. (1) Extensive skin blistering occurs due to minor trauma. (2) Gradually repeated blistering and fib

Evaluating Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa
737 Reached
Similar Content

Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Rubella Syndrome in Neonate
1396 Reached12 Comments9 Likes

Black Lesion in Old Female
1970 Reached5 Comments11 Likes

Chronic Hyperplastic Candidiasis Of The Oral Mucosa
857 Reached9 Comments11 Likes